These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 30676102)

  • 21. The effects of state rules on opioid prescribing in Indiana.
    Al Achkar M; Grannis S; Revere D; MacKie P; Howard M; Gupta S
    BMC Health Serv Res; 2018 Jan; 18(1):29. PubMed ID: 29347984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trends in First Gabapentin and Pregabalin Prescriptions in Primary Care in the United Kingdom, 1993-2017.
    Montastruc F; Loo SY; Renoux C
    JAMA; 2018 Nov; 320(20):2149-2151. PubMed ID: 30480717
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluating Emergency Department Opioid Prescribing Behaviors After Education About Mandated Use of the Pennsylvania Prescription Drug Monitoring Program.
    Martello J; Cassidy B; Mitchell A
    J Addict Nurs; 2018; 29(3):196-202. PubMed ID: 30180006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of gabapentin overdose using a poison center case series.
    Klein-Schwartz W; Shepherd JG; Gorman S; Dahl B
    J Toxicol Clin Toxicol; 2003; 41(1):11-5. PubMed ID: 12645962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A retrospective review of isolated gliptin-exposure cases reported to a state poison control system.
    Darracq MA; Toy JM; Chen T; Mo C; Cantrell FL
    Clin Toxicol (Phila); 2014 Mar; 52(3):226-30. PubMed ID: 24580063
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prescription Drug Monitoring Programs - Friend or Folly in Addressing the Opioid-Overdose Crisis?
    Haffajee RL
    N Engl J Med; 2019 Aug; 381(8):699-701. PubMed ID: 31433916
    [No Abstract]   [Full Text] [Related]  

  • 28. Evaluation of a Food and Drug Administration Mandate to Limit Acetaminophen in Prescription Combination Products.
    Goldberger D; Vearrier D
    J Med Toxicol; 2017 Dec; 13(4):303-308. PubMed ID: 28710607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Buprenorphine prescribing practices and exposures reported to a poison center--Utah, 2002-2011.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Dec; 61(49):997-1001. PubMed ID: 23235296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of New York prescription drug monitoring program, I-STOP, on statewide overdose morbidity.
    Brown R; Riley MR; Ulrich L; Kraly EP; Jenkins P; Krupa NL; Gadomski A
    Drug Alcohol Depend; 2017 Sep; 178():348-354. PubMed ID: 28692945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of narcotic prescription limiting legislation on opioid utilization following lumbar spine surgery.
    Reid DBC; Shah KN; Ruddell JH; Shapiro BH; Akelman E; Robertson AP; Palumbo MA; Daniels AH
    Spine J; 2019 Apr; 19(4):717-725. PubMed ID: 30223089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prescription Drug Monitoring Programs Are Associated With Sustained Reductions In Opioid Prescribing By Physicians.
    Bao Y; Pan Y; Taylor A; Radakrishnan S; Luo F; Pincus HA; Schackman BR
    Health Aff (Millwood); 2016 Jun; 35(6):1045-51. PubMed ID: 27269021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Impact of Prescription Drug Monitoring Programs and Prescribing Guidelines on Emergency Department Opioid Prescribing: A Multi-Center Survey.
    Pomerleau AC; Nelson LS; Hoppe JA; Salzman M; Weiss PS; Perrone J
    Pain Med; 2017 May; 18(5):889-897. PubMed ID: 26995800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phenibut exposures and clinical effects reported to a regional poison center.
    McCabe DJ; Bangh SA; Arens AM; Cole JB
    Am J Emerg Med; 2019 Nov; 37(11):2066-2071. PubMed ID: 30878413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Change in opioid use after the initiation of gabapentin therapy in patients with postherpetic neuralgia.
    Berger A; Dukes E; McCarberg B; Liss M; Oster G
    Clin Ther; 2003 Nov; 25(11):2809-21. PubMed ID: 14693306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessing The Impact Of State Policies For Prescription Drug Monitoring Programs On High-Risk Opioid Prescriptions.
    Bao Y; Wen K; Johnson P; Jeng PJ; Meisel ZF; Schackman BR
    Health Aff (Millwood); 2018 Oct; 37(10):1596-1604. PubMed ID: 30273045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mandatory Prescription Limits and Opioid Utilization Following Orthopaedic Surgery.
    Reid DBC; Shah KN; Shapiro BH; Ruddell JH; Akelman E; Daniels AH
    J Bone Joint Surg Am; 2019 May; 101(10):e43. PubMed ID: 31094987
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tramadol exposures reported to statewide poison control system.
    Marquardt KA; Alsop JA; Albertson TE
    Ann Pharmacother; 2005 Jun; 39(6):1039-44. PubMed ID: 15870139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative Rates of Mortality and Serious Adverse Effects Among Commonly Prescribed Opioid Analgesics.
    Murphy DL; Lebin JA; Severtson SG; Olsen HA; Dasgupta N; Dart RC
    Drug Saf; 2018 Aug; 41(8):787-795. PubMed ID: 29582394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trends in types of calls managed by U.S. poison centers 2000-2015.
    Anderson BD; Seung H; Klein-Schwartz W
    Clin Toxicol (Phila); 2018 Jul; 56(7):640-645. PubMed ID: 29205070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.